|
1
|
McCully KS: Vascular pathology of
homocysteinemia: Implications for the pathogenesis of
arteriosclerosis. Am J Pathol. 56:111–128. 1969.PubMed/NCBI
|
|
2
|
Moll S: Plasma homocysteine levels and
mortality in patients with coronary artery disease. N Engl J Med.
337:1631–1632; author reply 1632–1633. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Soinio M, Marniemi J, Laakso M, Lehto S
and Rönnemaa T: Elevated plasma homocysteine level is an
independent predictor of coronary heart disease events in patients
with type 2 diabetes mellitus. Ann Intern Med. 140:94–100. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arnesen E, Refsum H, Bønaa KH, Ueland PM,
Førde OH and Nordrehaug JE: Serum total homocysteine and coronary
heart disease. Int J Epidemiol. 24:704–709. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheng SW, Ting AC and Wong J: Fasting
total plasma homocysteine and atherosclerotic peripheral vascular
disease. Ann Vasc Surg. 11:217–223. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Graham IM, Daly LE, Refsum HM, Robinson K,
Brattström LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG,
Israelsson B, et al: Plasma homocysteine as a risk factor for
vascular disease. The European Concerted Action Project. JAMA.
277:1775–1781. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Perry IJ, Refsum H, Morris RW, Ebrahim SB,
Ueland PM and Shaper AG: Prospective study of serum total
homocysteine concentration and risk of stroke in middle-aged
British men. Lancet. 346:1395–1398. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Towfighi A, Saver JL, Engelhardt R and
Ovbiagele B: Factors associated with the steep increase in
late-midlife stroke occurrence among US men. J Stroke Cerebrovasc
Dis. 17:165–168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Homocysteine Studies Collaboration:
Homocysteine and risk of ischemic heart disease and stroke: A
meta-analysis. JAMA. 288:2015–2022. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boushey CJ, Beresford SA, Omenn GS and
Motulsky AG: A quantitative assessment of plasma homocysteine as a
risk factor for vascular disease. Probable benefits of increasing
folic acid intakes. JAMA. 274:1049–1057. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Selhub J: Homocysteine metabolism. Annu
Rev Nutr. 19:217–246. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McCully KS: Homocysteine and the
pathogenesis of atherosclerosis. Expert Rev Clin Pharmacol.
8:211–219. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nicholson JK, Lindon JC and Holmes E:
‘Metabonomics’: Understanding the metabolic responses of living
systems to pathophysiological stimuli via multivariate statistical
analysis of biological NMR spectroscopic data. Xenobiotica.
29:1181–1189. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wikoff WR, Gangoiti JA, Barshop BA and
Siuzdak G: Metabolomics identifies perturbations in human disorders
of propionate metabolism. Clin Chem. 53:2169–2176. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xue R, Lin Z, Deng C, Dong L, Liu T, Wang
J and Shen X: A serum metabolomic investigation on hepatocellular
carcinoma patients by chemical derivatization followed by gas
chromatography/mass spectrometry. Rapid Commun Mass Spectrom.
22:3061–3068. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bogdanov M, Matson WR, Wang L, Matson T,
Saunders-Pullman R, Bressman SS and Flint Beal M: Metabolomic
profiling to develop blood biomarkers for Parkinson's disease.
Brain. 131:389–396. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nicholson JK, Connelly J, Lindon JC and
Holmes E: Metabonomics: A platform for studying drug toxicity and
gene function. Nat Rev Drug Discov. 1:153–161. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Want EJ, Nordström A, Morita H and Siuzdak
G: From exogenous to endogenous: The inevitable imprint of mass
spectrometry in metabolomics. J Proteome Res. 6:459–468. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Joint Committee for Developing Chinese
guidelines on Prevention and Treatment of Dyslipidemia in Adults, .
Chinese guidelines on prevention and treatment of dyslipidemia in
adults. Zhonghua Xin Xue Guan Bing Za Zhi. 35:390–419. 2007.(In
Chinese). PubMed/NCBI
|
|
20
|
Chen C and Lu FC: Department of Disease
Control Ministry of Health, PR China: The guidelines for prevention
and control of overweight and obesity in Chinese adults. Biomed
Environ Sci. 17 Suppl:S1–S36. 2004.
|
|
21
|
Guo H, Chi J, Xing Y and Wang P: Influence
of folic acid on plasma homocysteine levels & arterial
endothelial function in patients with unstable angina. Indian J Med
Res. 129:279–284. 2009.PubMed/NCBI
|
|
22
|
Xu J, Tian YP, Chen YH, Zhang RP, Yang F,
Song YM and Zeper A: Plasma preparation method for metabollomic
analysis based on rapid resolution liquid chromatography-mass
spectrometry. Chin J Anal Chem. 39:1793–1797. 2011. View Article : Google Scholar
|
|
23
|
Smith CA, Want EJ, O'Maille G, Abagyan R
and Siuzdak G: XCMS: Processing mass spectrometry data for
metabolite profiling using nonlinear peak alignment, matching, and
identification. Anal Chem. 78:779–787. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xia J, Mandal R, Sinelnikov IV, Broadhurst
D and Wishart DS: MetaboAnalyst 2.0-a comprehensive server for
metabolomic data analysis. Nucleic Acids Res. 40:(Web Server
Issue). W127–W133. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xia J, Sinelnikov IV, Han B and Wishart
DS: MetaboAnalyst 3.0-making metabolomics more meaningful. Nucleic
Acids Res. 43(W1): W251–W257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia J and Wishart DS: MetPA: A web-based
metabolomics tool for pathway analysis and visualization.
Bioinformatics. 26:2342–2344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xue SS, He JL, Zhang X, Liu YJ, Xue FX,
Wang CJ, Ai D and Zhu Y: Metabolomic analysis revealed the role of
DNA methylation in the balance of arachidonic acid metabolism and
endothelial activation. Biochim Biophys Acta. 1851:1317–1326. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Capdevila JH, Falck JR and Harris RC:
Cytochrome P450 and arachidonic acid bioactivation. Molecular and
functional properties of the arachidonate monooxygenase. J Lipid
Res. 41:163–181. 2000.PubMed/NCBI
|
|
29
|
Wang Y, Wei X, Xiao X, Hui R, Card JW,
Carey MA, Wang DW and Zeldin DC: Arachidonic acid epoxygenase
metabolites stimulate endothelial cell growth and angiogenesis via
mitogen-activated protein kinase and phosphatidylinositol
3-kinase/Akt signaling pathways. J Pharmacol Exp Ther. 314:522–532.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xiao B, Li X, Yan J, Yu X, Yang G, Xiao X,
Voltz JW, Zeldin DC and Wang DW: Overexpression of cytochrome P450
epoxygenases prevents development of hypertension in spontaneously
hypertensive rats by enhancing atrial natriuretic peptide. J
Pharmacol Exp Ther. 334:784–794. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Smith GI, Atherton P, Reeds DN, Mohammed
BS, Rankin D, Rennie MJ and Mittendorfer B: Omega-3 polyunsaturated
fatty acids augment the muscle protein anabolic response to
hyperaminoacidemia-hyperinsulinemiain healthy young and middle-aged
men and women. Clin Sci (Lond). 121:267–278. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Imig JD and Hammock BD: Soluble epoxide
hydrolase as a therapeutic target for cardiovascular diseases. Nat
Rev Drug Discov. 8:794–805. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nishimura M, Hirai A, Omura M, Tamura Y
and Yoshida S: Arachidonic acid metabolites by cytochrome P-450
dependent monooxygenase pathway in bovine adrenal fasciculata
cells. Prostaglandins. 38:413–430. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Capdevila J, Marnett LJ, Chacos N, Prough
RA and Estabrook RW: Cytochrome P-450-dependent oxygenation of
arachidonic acid to hydroxyicosatetraenoic acids. Proc Natl Acad
Sci USA. 79:pp. 767–770. 1982; View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ma C, Wang Y, Shen T, Zhang C, Ma J, Zhang
L, Liu F and Zhu D: Placenta growth factor mediates angiogenesis in
hypoxic pulmonary hypertension. Prostaglandins Leukot Essent Fatty
Acids. 89:159–168. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Blazevic T, Schwaiberger AV, Schreiner CE,
Schachner D, Schaible AM, Grojer CS, Atanasov AG, Werz O, Dirsch VM
and Heiss EH: 12/15-lipoxygenase contributes to platelet-derived
growth factor-induced activation of signal transducer and activator
of transcription 3. J Biol Chem. 288:35592–35603. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bellien J and Joannides R:
Epoxyeicosatrienoic acid pathway in human health and diseases. J
Cardiovasc Pharmacol. 61:188–196. 2013. View Article : Google Scholar : PubMed/NCBI
|
